Patents by Inventor Zoe PRENTICE

Zoe PRENTICE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124458
    Abstract: The present invention relates to crystalline and non-crystalline forms of avapritinib, to processes for their preparation, and to pharmaceutical compositions containing the crystalline or non-crystalline forms.
    Type: Application
    Filed: October 23, 2020
    Publication date: April 18, 2024
    Inventors: Thierry BONNAUD, Zoe PRENTICE
  • Publication number: 20230126277
    Abstract: The present invention relates to crystalline forms of voxelotor, to processes for their preparation, and to pharmaceutical compositions containing the crystalline forms.
    Type: Application
    Filed: February 17, 2021
    Publication date: April 27, 2023
    Inventors: Thierry BONNAUD, Zoe PRENTICE
  • Publication number: 20230068593
    Abstract: The present invention is directed to processes for making various polymorphs of tucatinib, designated herein as Form I, Form II, and Form III of tucatinib. These forms can then be used to prepare pharmaceutical formations containing tucatinib. Tucatinib is a tyrosine kinase inhibitor that is indicated for the treatment of breast cancer.
    Type: Application
    Filed: July 27, 2022
    Publication date: March 2, 2023
    Inventors: Thierry BONNAUD, Adam Ross PATTERSON, Zoe PRENTICE, Mark Alexander WRIGHT
  • Publication number: 20220372024
    Abstract: The present invention relates to crystalline forms of entrectinib, processes for their preparation, and to pharmaceutical compositions containing the crystalline forms.
    Type: Application
    Filed: October 30, 2020
    Publication date: November 24, 2022
    Inventors: Thierry BONNAUD, Zoe PRENTICE, Adam PATTERSON
  • Publication number: 20220194946
    Abstract: The disclosure is in part directed to crystalline forms of N-(4-(4-amino-5-(3-fluoro-4-(4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenyl)methacrylamide, its salts, its cocrystals, and variants thereof.
    Type: Application
    Filed: November 18, 2021
    Publication date: June 23, 2022
    Inventors: André LESCARBEAU, Jethro BEAMISH-COOK, Zoe PRENTICE, Thomas KENDALL, Aaron DUMAS, Elisabeth ISAAK, Piera TRINCHERA, Oleksandr ZHURAKOVSKYI, Osama SULEIMAN